Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Generic Protonix Recall Issued Over Glass Particle Contamination December 20, 2017 Irvin Jackson Add Your Comments A recall has been issued for certain vials of generic Protonix I.V., an injectable heartburn drug, due to a risk that it may be contaminated with glass particles. The FDA announced a Pantoprazole Sodium recall at the hospital level on December 19, impacting 40 mg vials distributed by AuroMedics Pharma LLC. The generic Protonix recall came after the manufacturer received a complaint that a piece of glass was found in one of the vials. AuroMedics and the FDA warn that injecting drugs with glass particulate matter present could result in local irritation, swelling, or more serious adverse health side effects such as blocking and clotting blood vessels, which could cause life-threatening injuries. There are no reports of injuries or adverse health events linked to the generic Protonix I.V. recall. Learn More About Nexium, Prilosec and Other Acid Reflux Drug Lawsuits Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Nexium, Prilosec and Other Acid Reflux Drug Lawsuits Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The recall affects one lot of pantoprazole sodium for injection, 40 mg per vial, distributed in cartons containing 10 vials. The affected vials have an NDC number of 55150-202-10. The lot number is CPO170035, with an expiration date of May 2019. The vials have a grey, slotted rubber stopper, aluminum seals, and a Sky Blue colored polypropylene disc. The recalled vials were distributed on August 7, 2017. The company indicates that it is notifying distributors and customers by mail and is arranging for their return or replacement. Pantoprazole sodium is the injectable generic form of the proton pump inhibitor (PPI) Protonix I.V., which is used for short-term relief from symptoms of gastroesophageal reflux disease (GERD) associated with erosive esophagitis and pathological hypersecretion, including zollinger-ellison syndrome. Other PPIs include Nexium, Prevacid and Prilosec, though they are most commonly taken in pill form. PPI Health Risks The recall comes as the entire class of heartburn drugs have come under scrutiny due to potential kidney injury side effects, with several recent studies suggesting that use of the heartburn drugs increases the risk of acute kidney injury, chronic kidney disease and potentially kidney failure. In late 2014, the FDA added heartburn drug warnings about the risk of C. Diff associated diarrhea, and also indicated at that time that the medications have been linked to reports of acute interstitial nephritis, which involves kidney inflammation that may lead to more serious problems. According to a study published by the medical journal CMAJ Open in April 2015, researchers indicated that users of Nexium, Prilosec or other heartburn drugs face an increased risk of kidney injury, which may lead to kidney failure. This research was followed by a study published in the medical journal JAMA Internal Medicine in January 2016, which found that users also face an increased risk of chronic kidney disease from heartburn drugs. Those findings were supported by another study published in April 2016, in which researchers with the Department of Veterans Affairs found that users of Nexium, Prilosec or other PPIs may be 96% more likely to develop kidney failure and 28% more likely to develop chronic kidney disease after five years of use.“ A number of individuals throughout the United States who have suffered acute kidney injury, chronic kidney disease or renal failure are now pursuing potential Nexium lawsuits, Prilosec lawsuits and other claims against makers of proton pump inhibitors (PPI), alleging that the risk of kidney problems should have been included among warnings provided to consumers and the medical community. Customers with questions about the AuroMedics pantoprazole sodium injection recall can contact Aurobindo Customer Service by calling 866-850-2876 and selecting Option 1. Those in need of assistance returning the affected vials can contact Inmar by calling 800-967-5952. Patients are urged to contact their healthcare provider if they experience any adverse side effects after receiving pantoprazole sodium. Adverse health events should also be reported to the FDA’s MedWatch Adverse Event Reporting program. Tags: Drug Recall, Heartburn, Heartburn Drugs, intravenous, Kidney Failure, Nexium, Particulate Matter, Prevacid, Prilosec, Proton Pumb Inhibitor, Protonix More Proton Pump Inhibitor Lawsuit Stories Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm April 15, 2024 Nexium, Prilosec Settlement Reached To Resolve Kidney Damage Lawsuits Against AstraZeneca October 4, 2023 Heartburn Drugs Like Nexium, Prilosec May Increase Risk of Serious Childhood Infections: Study August 17, 2023 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: today) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: today) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm April 15, 2024
Nexium, Prilosec Settlement Reached To Resolve Kidney Damage Lawsuits Against AstraZeneca October 4, 2023
Heartburn Drugs Like Nexium, Prilosec May Increase Risk of Serious Childhood Infections: Study August 17, 2023
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: today) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: today) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)